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The neuregulin-1 (NRG1) gene is one of the best-validated risk genes for schizophrenia, and psychotic and bipolar disorders. The
rs6994992 variant in the NRG1 promoter (SNP8NRG243177) is associated with altered frontal and temporal brain macrostructures
and/or altered white matter density and integrity in schizophrenic adults, as well as healthy adults and neonates. However, the ages
when these changes begin and whether neuroimaging phenotypes are associated with cognitive performance are not fully
understood. Therefore, we investigated the association of the rs6994992 variant on developmental trajectories of brain macro- and
microstructures, and their relationship with cognitive performance. A total of 972 healthy children aged 3–20 years had the
genotype available for the NRG1-rs6994992 variant, and were evaluated with magnetic resonance imaging (MRI) and
neuropsychological tests. Age-by-NRG1-rs6994992 interactions and genotype effects were assessed using a general additive model
regression methodology, covaried for scanner type, socioeconomic status, sex and genetic ancestry factors. Compared with the
C-carriers, children with the TT-risk-alleles had subtle microscopic and macroscopic changes in brain development that emerge or
reverse during adolescence, a period when many psychiatric disorders are manifested. TT-children at late adolescence showed a
lower age-dependent forniceal volume and lower fractional anisotropy; however, both measures were associated with better
episodic memory performance. To our knowledge, we provide the ﬁrst multimodal imaging evidence that genetic variation in NRG1
is associated with age-related changes on brain development during typical childhood and adolescence, and delineated the altered
patterns of development in multiple brain regions in children with the T-risk allele(s).
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INTRODUCTION
The neuregulin-1 gene (NRG1) encodes many structural and
functional isoforms through alternative promoter usage (type
I–IV).
1,2 These isoforms are involved in neuronal and glial
development and synaptic plasticity.
3–6 Variants in NRG1 are
associated with the diagnoses of schizophrenia and psychiatric
disorders,
7–17 and contribute to impaired brain functions in those
patients.
18,19 The rs6994992 (SNP8NRG243177) is one of the most
studied genes associated with increased risk for schizophrenic and
psychotic symptoms, as well as cognitive deﬁcits in
schizophrenics.
20–22 This speciﬁc variant was also suggested to
predict transition to psychosis in three independent cohorts with
very high risk for psychosis.
20,23,24 Moreover, genetic variations at
rs6994992 altered the promoter activity of the type IV NRG1
isoform, which is expressed speciﬁcally in the brain and especially
during the fetal period.
25 Higher transcript levels of type IV NRG1
were also found in post-mortem brains of both healthy and
schizophrenic adults with the TT-risk alleles.
2 Variation at
rs6994992 in the type IV NRG1 results in differential expression
that may have a critical role in the schizophrenia and psychosis
pathology.
Several magnetic resonance imaging (MRI) studies reported that
NRG1-rs6994992 is associated with alterations in brain volumes
and white matter integrity. In healthy adults, the T-risk allele is
associated with smaller gray matter volumes in several gyri,
26
higher white matter density in the right anterior internal capsule
27
and lower white matter integrity in the left anterior thalamic
radiation.
22,26 Furthermore, adults with ﬁrst-onset schizophrenia
had T-allele dose-dependent increases in lateral ventricle
volumes.
28 Similar enlargements of the lateral ventricles along
with altered developmental trajectories of gray and white matter
were observed in TT-children (age 8–20 years) with childhood-
onset schizophrenia compared with the C-carriers.
29 In contrast,
healthy neonates with the rs6994992-TT and parental psychiatric
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www.nature.com/tphistory (that is, bipolar disorder, depression, drug dependence/
abuse) showed greater gray matter volumes in the frontal and
temporal lobes than the C-carriers.
30
Genetic inﬂuences on brain development can change with
age
31 and be modiﬁed by the environment.
32 Therefore, we
propose that modulation of the NRG1 expression through genetic
variation at the rs6694992 inﬂuences brain development and may
show a pleiotropic effect in different brain structures, as well as an
antagonistic pleiotropic effect at different age during normal brain
development. To our knowledge, no study evaluated whether the
functional rs6994992 variant inﬂuences age-related brain devel-
opment from early childhood to late adolescence in a large
population and at micro- and macrostructural levels.
Cross-sectional studies across a large age span make it possible
to evaluate age-dependent trajectories of brain development in
relation to this particular genetic variation, and may improve our
understanding of when these gene-related brain changes occur.
The period of brain maturation in adolescence and early
adulthood is a vulnerable time during which many mental
illnesses are ﬁrst expressed. Therefore, we investigated macro-
and microstructural brain changes, using MRI, in a large cohort of
healthy children aged 3–20 years. We focused on brain regions
known to be associated with schizophrenia pathology, and
reportedly affected by the rs6994992 variant (that is, mainly in
the temporal, frontal and parietal lobes). Speciﬁcally, we
hypothesized that compared with CC-alleles children, those with
TT-alleles have differential age-dependent trajectories of micro-
and macro-brain structures in these regions.
Furthermore, a recent meta-analysis found that schizophrenic
patients consistently showed slower processing speed and poorer
episodic memory than healthy controls.
33 Therefore, we further
evaluated whether the brain changes identiﬁed in the TT-children
correlate with performance in these two domains.
MATERIALS AND METHODS
Data were obtained from the Pediatric Imaging Neurocognition and
Genetic (PING) study database (http://ping.chd.ucsd.edu). PING is a cross-
sectional normative data set from 1400 typically developing children aged
3–20 years that was collected across ten academic institutions in the
United States. The data set includes whole genome single-nucleotide
polymorphism genotype, developmental and neuropsychological assess-
ments (NIH Toolbox) and high-resolution brain MRI. The human research
protection programs and institutional review boards of the participating
institutions approved the design, experiments and consents (oral and
written) used for the PING study.
Subjects
A total of 972 children from the PING database were included in this study.
Details on recruitment and subject characteristics were reported
previously.
34–37 Informed consent was obtained either from the partici-
pants (⩾18 years old), or from their parents (<18 years of age) with child
assent (7–17 years of age). Healthy children were screened to ensure that
they had no self-reported or parent-reported history of major develop-
mental, psychiatric or neurological disorders, brain injury or other medical
conditions that would affect their brain development. Of the total, 250
children were additionally examined by a physician to ensure their healthy
status before enrollment. Individuals born prematurely (<36 weeks
gestational age), with signiﬁcant prenatal drug or alcohol exposure or
with contraindications for MRI (for example, metallic or electronic implants,
claustrophobia, dental braces or pregnancy) were also excluded.
Genotyping, genotype imputation and genetic ancestry factor
Genomic DNA was extracted from saliva for genotyping using the Illumina
Human660W-Quad BeadChip. Replication and quality control ﬁlters (that is,
sample call rate >99%, call rates >95%, minor allele frequency >5%) were
performed.
38 To assess reproducibility, about 1% of the samples were
genotyped in duplicates to compare genotypes. The rs6994992 variant
located on chromosome 8 in the promoter region of the neuregulin-1
gene was imputed using MACH1.0
39 with the default settings and a quality
control (R>0.5) for all individuals from the PING database as of 6 April 2013.
To control for race/ethnicity on the outcome measures, genetic ancestry
factors (GAFs) were estimated using a standard method that includes
multidimensional scaling analysis and actual estimates of local ancestry in
admixed populations (LAMP)
40 as previously described.
37
Image acquisition and image processing
The neuroimaging techniques, data acquisition and analyses were
reported previously
34–36 and are available on the PING website (http://
ping.chd.ucsd.edu). Brieﬂy, MRI was performed on ten 3 Tesla scanners
from three manufacturers (Siemens, Erlangen, Germany; General Electric
Medical, Milwaukee, WI, USA; two Philips Medical, Andover, MA, USA). On
the Siemens scanners, MRI included a three-dimensional T1-weighted
structural scan (TR/TE/TI=2170/2.78/1100ms, 7-degree ﬂip angle,
1.0×1.0×1.2mm
3 resolution, 8 min acquisition time), a T2-weighted
volume and a set of diffusion-weighted scans (dual spin-echo echo-planar
imaging, TR/TE=9500/91s, 2 averages, 2.5mm isotropic resolution, b-
values=1000s mm
−2, 30 diffusion directions, 10min acquisition time).
Imaging protocols for the other scanner platforms closely matched those
for the Siemens scanners. Prospective motion compensation
41 was used
for 74% of the T1-weighted scans at UCSD
34 and 10.5% of those in Hawaii.
After transferring the MRI data to the central processing site (UCSD) in
DICOM format, all the images were automatically checked for protocol
compliance on the basis of DICOM header information, and visually
inspected for artifacts, including motion artifacts, signal inhomogeneities
and ghosting. Scans rated as unacceptable on any rating were excluded
from the study.
Image analyses were performed using a modiﬁed Freesurfer software
suite (http://surfer.nmr.mgh.harvard.edu/) that is based on routine three-
dimensional T1-weighted MRI volumes. FreeSurfer provides a method for
automatic parcellation of the cortical surface, by which each location on
the surface is assigned a neuroanatomical label on the basis of
probabilistic information estimated from a manually labeled training set.
Details on surface-based cortical reconstruction and subcortical volumetric
segmentation were reported previously.
34 Delineation and labeling of the
white matter tracts were performed with the atlas-based method,
AtlasTrack, using diffusion tensor images (DTIs), T1-weighted images and
a probabilistic atlas of ﬁber tract locations and orientations.
42 Validated for
use in pediatric populations, AtlasTrack provides estimates for each tract
the average mean diffusion, transverse and longitudinal diffusivity (TD and
LD, respectively) and fractional anisotropy (FA).
Fiber tract volumes were calculated as the number of voxels with ﬁber
probability estimates greater than 0.08.
Of the 972 children with rs6994992 imputed, all met quality criteria for
cortical and subcortical measurements (thickness, area, volume), and 891
for DTI measures (81 children had DTI scans that did not meet the quality
criteria, and were excluded from our analysis. Out of the 81 children, 43 TC/
28 CC/10TT, Hardy–Weinberg equilibrium χ
2=0.48, P=0.49). However, as
we controlled for socioeconomic status, sex, device number and GAF in all
the statistical models, only 897 children were included in the cortical and
subcortical analysis and 822 for the DTI analysis.
Episodic memory and processing speed
The NIH Toolbox Cognition Battery evaluates six major cognitive
domains.
37,43 We analyzed data from two tasks that represent the two dom-
ains implicated previously in schizophrenia: episodic memory (picture
sequence memory test) and processing speed (pattern comparison process-
ing speed test).
33 The picture sequence memory test ﬁrst presents a
sequence of thematically related pictures to the child on a computer screen,
and then requires the child to sort a sequence of reshufﬂed pictures back to
the order that was shown previously. Six to 18 items in each sequence over
three trials were presented depending on the child’s age (outcome:
cumulative correct responses from a maximum of 18–48). For the pattern
comparison processing speed task, the child has to determine whether two
side-by-side pictures are similar by touching the smiley face or a sad face
icon (ages 3–7 years), or a ‘yes’ or ‘no’ button (>7 years old), response on the
screen (outcome: correct responses within the 90s time limit).
Statistics
Statistical analyses were performed using a customized user interface for
the PING database, called ‘Data Portal’ (https://ping-dataportal.ucsd.edu/).
The ‘Data Portal’ enables statistical analysis of genotype- and genotype-by-
age effects on neural architectural phenotypes (from the imaging data),
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measures using a general additive model
44 as implemented by the R
program (http://www.r-project.org/). General additive model is a multiple
linear regression model that allows smooth functions of the predictor
variables or covariates where the degree of smoothness is data-driven
rather than pre-speciﬁed.
44 Each statistical model used age as a smooth
independent variable, and included a linear term for the genotype and a
smooth interaction between age and genotype. Also, all models accounted
for group differences in socioeconomic status (reﬂecting the highest
parental education and household income), sex, GAF
37 and study site.
Cohen’s ƒ
2 effect sizes were calculated to estimate the contribution of
smooth age-by-genotype interactions. Cortical area and thickness were
additionally adjusted for the total mean
45 and subcortical volumes for
intracranial volume. As cortical volumes are derived from regional areas
and thickness, cortical volumes will not be reported to minimize multiple
comparisons. For the vertex-based models, signiﬁcance maps for cortical
area and thickness were thresholded using the false discovery rate to
correct for multiple comparisons at the 5% level.
46 For the region of
interest (ROI)-based models, 44 cortical structures (22 for each hemisphere)
were considered in this study, including mainly the temporal, frontal and
parietal lobes. To correct for multiple comparisons we used Holm-
Bonferroni sequential correction that involved a stepwise rejective multiple
test procedure, testing the most extreme P-value against the strictest
criterion, and the others against progressively less strict criteria.
47,48 Results
on the areas or thickness of the cortical structures were then considered
signiﬁcant when adjusted P-values wereo0.003 (α=0.05). Five sub-
cortical ROIs and lateral ventricles showed no hemispheric differences and
were averaged before evaluating genotype and age-by-genotype effects.
The subcortical ROI results were considered signiﬁcant when adjusted
P-valueso0.01 (α=0.05). Likewise, as the measures for the six white
matter tracts that were shown to be abnormal in patients with
schizophrenia or altered in those with the T-risk allele (ALIC, ATR, fornix,
corpus callosum, superior longitudinal fasciculus, uncinate)
20,27 showed
no hemispheric differences, the values were averaged and adjusted
P-valueso0.01 (α=0.05) were considered signiﬁcant.
RESULTS
Participant characteristics
This study involved 972 children (mean age 12.07±4.97 years; 462
girls and 510 boys; Table 1). The genotype distribution for the
rs6994992 variant across all subjects did not deviate from the
Hardy–Weinberg equilibrium (P=0.38). Children in the three allele
groups were similar in age, sex proportion, household income and
parents/guardians’ highest level of occupation. However, the
genotype groups differed by GAFs and the highest level of
education of the parents/guardians. As expected, the frequency of
TT genotype was lower than TC or CC genotypes in children with
European and American Indian GAF and higher in children with
East-Asia or with Central-Asia GAF. Hence, GAF was controlled for
in each statistical model.
The rs6994992-T- allele is associated with altered development of
subcortical structures
Consistent with prior reports,
49,50 the volumes of pallidum,
putamen, hippocampus and thalamus increased with age, but
no genotype effects were found for these structures
(Supplementary Table 1). On DTI, FA increased with age in basal
ganglia structures (pallidum, caudate, putamen) and thalamus, but
not in the hippocampus. Conversely, diffusivity (mean diffusion,
LD and TD) generally showed age-related decreases in these
subcortical structures. Age-by-genotype interactions were primar-
ily found on FA in the basal ganglia. The age-related trajectories
were signiﬁcantly altered in the T-carriers for LD in the thalamus
(Figure 1) and for TD in the putamen (Supplementary Figure 1)
and pallidum (Figure 1). Furthermore, T-carriers had a higher FA in
the pallidum than CC-carriers during adolescence but lower FA
during younger childhood (Figure 1). Similar patterns were also
found for the caudate and putamen (Supplementary Figure 1).
Conversely, TD in these regions was higher in T-carriers than CC-
carriers at younger ages, but showed a lower age-related TD
during adolescence (Figure 1). Similar to schizophrenic adults,
28
healthy TT-adolescents (>14 years of age) showed a trend for
larger and steeper age-dependent increase in the lateral ventricles
compared with C-carriers, leading to 37% larger estimated
volumes at 20 years of age (Figure 1). Our statistical model
explained 23.4% of the variance of the lateral ventricle volumes
(age-by-genotype interaction, P=0.02, R
2 (adjusted)=0.21, effect
Table 1. Participant characteristics (all values are in mean±s.e.)
TT TC CC One-way ANOVA or χ
2
P-value
Children characteristics
NRG1 genotype frequency, n (%) 154 (15.84) 484 (49.79) 334 (34.36) 0.38 (HWE P-value)
Age (years) 11.87±0.41 12.11±0.23 12.10±0.26 0.87 (F0.14, 971,2)
a
Boys/girls 80/74 258/226 171/163 0.83 (χ
2
0.36, 972,2)
b
GAF_Europe (%) 0.53 ±0.03 (29) 0.63±0.02 (36) 0.66 ±0.02 (35) 0.001 (F6.68, 970,2)
a
GAF_Africa (%) 0.90±0.02 (79) 0.11±0.01 (10) 0.13±0.01 (11) 0.24 (F1.42, 970,2)
a
GAF_American Indian (%) 0.02±0.005 (17) 0.04±0.005 (33) 0.06±0.007 (50) 0.0005 (F7.61, 970,2)
a
GAF_East Asia (%) 0.30±0.03 (51) 0.18±0.01 (30) 0.12±0.01 (19) o0.0001 (F16.52, 970,2)
a
GAF_Oceania (%) 0.01±0.003 (38) 0.008±0.001 (31) 0.008±0.002 (31) 0.30 (F1.20, 970,2)
a
GAF_Central Asia (%) 0.05±0.01 (56) 0.03±0.006 (33) 0.01±0.005 (11) 0.06 (F2.91, 970,2)
a
Parent/guardian characteristics
Household income (1= o$5K, 6=40K–50K, 12=⩾$300K) 6.78±0.19 6.84±0.11 6.62±0.14 0.44 (F0.81, 928,2)
a
Highest education (7=professional, 4=high school graduate,
1= o7 years of school)
5.91±0.09 5.91±0.05 5.64±0.06 0.002 (F6.31, 938,2)
a
Highest occupation ( 7=higher executives, 4=clerical & sales
workers, 1=unskilled employee)
5.19±0.13 5.18±0.308 4.99±0.09 0.23 (F1.47, 892,2)
a
MR scanners
General Electric Medical 25 98 66 0.39 (χ
2
4.15, 972,4)
b
Philips Medical 18 79 54
Siemens 111 307 214
Abbreviations: ANOVA, analysis of variance; HWE, Hardy–Weinberg equilibrium; MR, magnetic resonance.
aF-value, sample size and degree of freedom.
bχ2
value, sample size and degree of freedom. CC, TC and TT are genotypes. Signiﬁcant genotype effects were observed only on the genetic ancestry factor (GAF)
and highest education.
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2) =0.266, power >0.90, α=0.05; a model excluding
genotype explained only 11% of the variance).
The rs6994992-T-risk allele alters development of cortical
morphometry
Figure 2 summarizes age-by-genotype interactions and genotype
effects on developmental trajectories of the cortex using both
vertex-based (Figure 2a) and ROI-based (Figure 2b) models. On
both models, age-by-genotype interactions were found predomi-
nantly in the temporal, parietal and frontal lobes. For instance, the
vertex-based model showed age-by-genotype interactions in
thickness for the right supramarginal gyrus, the right superior
temporal gyrus and the left fusiform, and in area for the middle
frontal, inferior parietal right caudal anterior cingulate and left
precuneus (Figure 2a). Most of the cortical phenotypes affected by
the NRG1 variant emerged or reversed during adolescence
(Supplementary Figures 2–5).
Three general patterns of age-by-genotype interaction were
observed with the ROI-based models (Figure 3). The ﬁrst pattern
is exempliﬁed by the rostral middle frontal gyrus surface area.
Young TT-children did not exhibit genotype differences, but TT-
adolescents showed a lesser age-related decline in area (Figure 3a)
relative to C-carriers. This pattern was also observed for the area of
the right frontal pole (Supplementary Figure 2).
The second pattern involved a reversal of neuroimaging
phenotypes with age, commonly with a crossing of trajectories
during adolescence. For instance, in the right caudal middle
frontal gyrus, young TT-children had a larger area than C-carriers,
whereas TT-adolescents had a smaller area (Figure 3b). Similar
interactions were found for the area of the lateral orbitofrontal
cortex and the thickness of the left supramarginal gyrus
(Supplementary Figures 3). Conversely, in the left caudal anterior
cingulate, younger TT-children had smaller area (Figure 3c) and
thickness (Supplementary Figure 3) than C-carriers, whereas the
differences were reversed in adolescents. The right superior
frontal gyrus exhibited this pattern on thickness, and the right
inferior temporal gyrus on area (Supplementary Figure 3).
The third pattern was found for the right superior temporal
gyrus, where the age-related curve of the TT-carriers for area
followed a U-shape with a trough at 12.5 years of age, whereas a
slightly inverted U-shape was observed in the C-carriers
(Figure 3d). This pattern was also found for the thickness of the
right inferior parietal cortex (Supplementary Figure 4).
Independent of age and compared with CC-carriers, TT-children
had larger area of the right inferior parietal cortex (Supplementary
Figure 5) and showed a steeper decrease in area of the left
precuneus (Supplementary Figure 5).
The rs6994992-T-risk allele is associated with alterations in
forniceal white matter
Among the white matter tracts evaluated (ALIC, ATR, Fornix,
Corpus callosum, SLF), an age-by-genotype interaction was found
only in the fornix volume and DTI metrics (Figure 4). TT-children
showed inverted U-shapes in the growth of the volume (peaking
at 11.5 years) and FA (peaking at 14 years) of the fornix.
Conversely, CC-carriers showed continued growth or a plateau in
both metrics during their second half of adolescence (Figures 4a
and b). These differential developmental trajectories resulted in
smaller volume (−6.1%) and lower FA (−3.4%) in TT-children
compared with CC-children by age 20.
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Figure 1. Age-related differences in DTI metrics of subcortical structures (top row) and in lateral ventricle volume (bottom row). Percentages
are expressed as increases (sign +) or decreases (sign −) in values between the TT-children (green) and the CC-children (blue). Black vertical
arrows indicate when the age-by-genotype interactions emerge or reverse. The bottom right panel illustrates the location of subcortical
structures of interest, as well as a statistical P-value map for FA generated with the ROI-based model. DTI, diffusion tensor image; FA, fractional
anisotropy; LD, longitudinal diffusivity; ROI, region of interest; TD, transverse diffusivity.
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FA of the fornix actually had higher picture sequence memory test
scores (better episodic memory; Figure 4c). No signiﬁcant
correlations were found between pattern comparison processing
speed test scores (processing speed) and brain imaging measures
in the fornix.
DISCUSSION
To our knowledge, this is the ﬁrst demonstration that the
functional genetic variant rs6994992 in the NRG1 gene is
associated with both microscopic and macroscopic alterations in
brain development of typically developing healthy children and
adolescents. Although the changes are subtle, some of our
ﬁndings on cortical structures are consistent with those reported
in neonates with high familial risk for psychosis
30 and in
schizophrenic adults and adolescents.
26–28 This is also the ﬁrst
report to show that most of the NRG1-rs6994992 effects on
neuroimaging phenotypes emerge or reverse during adolescence.
Therefore, the neuroimaging phenotypes associated with this risk
gene appear to evolve coincidentally with mental disorders that
often emerge during adolescence, most likely due to the
differential expression of the type IV NRG1 mediated by variation
at rs6994992.
The NRG1-rs6994992 variant is located in the alternative
promoter region of type IV NRG1, and those with the TT-alleles
produce higher transcript levels (up to 40% higher) of the type IV
NRG1 than those with the CC-alleles, as shown in the post-mortem
brains of both healthy and schizophrenic individuals.
2 Likewise,
the NRG1 promoter of the T-alleles is 65% more active than that of
C-alleles in cell cultures.
25 Therefore, rs6994992-TT children might
produce more type IV NRG1 during brain development, which
could lead to structural changes that ultimately increase the risk
for mental disorders. However, the associated cellular mediators
on structural MRI measures are unknown, and thus the molecular
mechanism implicating type IV NRG1 remains speculative.
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Figure 2. Summary of NRG1 genotype main effects and age-by-genotype interactions in cortical measures. (a) Statistical P-value maps
showing signiﬁcant interactions between smooth age and the three NRG1 genotypes (TT, TC and CC) in healthy children. The maps were
generated from general additive models with cortical area and thickness as the dependent variable at each location (vertex) across the
surface. Sex, device, GAF, SES were included as covariates, and ﬁndings were corrected for multiple comparisons with false discovery rate
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of NRG1-rs6994992 genotype differences and genotype-by-age interactions on cortical structures. The P-values (two-way analysis
of covariance) of regions showing statistical differences with both the ROI-based and the vertex-based models are indicated in italic. The
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© 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1–9Nevertheless, assessing how this variant affects brain develop-
ment and whether the expression of type IV NRG1 through this
variation is involved in this process may lead to new therapeutic
targets.
On cortical structures, both vertex- and ROI-based analyses
showed that genetic variation at rs6994992 is associated primarily
with alterations in the growth trajectories of the cortical area, and
hence volume, in the frontal, temporal and parietal lobes. Our
ﬁndings are consistent with a prior study that showed TT-allele
children with childhood-onset schizophrenia had greater total
gray matter volume and changes in shapes and forms of
the frontal, temporal and parietal lobes.
29 Similar to our study,
TT-neonates with high familial risk for psychosis had larger
volumes than C-carriers primarily in the frontal and temporal
lobes, and smaller volumes in several smaller regions across the
brain.
30 In addition, our study demonstrates that variation at
rs6994992 affects regions that are often associated with volume
loss in adolescents with ultra-high risk for psychosis, such as that
in the left caudal anterior cingulate
51 and left precuneus.
52
Replicating ﬁndings of rs6994992 effects on cortical structures in
such a large cohort of typically developing children strongly
supports the biological relevance of the gene’s effects on newly
identiﬁed regions involved in psychosis, such as the right inferior
parietal gyrus or the supramarginal gyrus. However, these prior
studies did not investigate age-by-NRG1 genotype interactions,
perhaps due to the smaller sample size and narrower age ranges.
Larger ventricular volume in TT-carriers compared with
C-carriers started in adolescence. Although the statistical sig-
niﬁcance for this trait is borderline (P=0.02), similar ventricular
enlargement associated with the rs6994992 variant was reported
in schizophrenic adults and unaffected relatives,
28 as well as in
children with childhood-onset schizophrenia (8–20 years of age).
29
On subcortical structures, we did not ﬁnd smaller basal ganglia
and thalamus volumes as reported in TT-neonates.
30 However,
NRG1-related alterations were observed on striatal FA, an indicator
of white matter coherence and axonal organization,
53 and on TD,
which may reﬂect myelination or glial cell morphology.
54–56
Therefore, the rs6994992 variant may affect white matter through
myelination rather than axonal integrity, since the LD was
normal.
55,57 In contrast, the rs6994992 variant may affect the
axonal integrity or extracellular space of the thalamus, as indicated
by changes in both the LD and FA. Again, these subcortical
changes typically emerged at adolescence. These results highlight
the pleiotropic role of the rs6994992-NRG1 T-risk allele on brain
development, and suggest that peripubertal factors, such as
hormones or environment, might further impact the gene
expression.
The developmental trajectories of FA, mean diffusion and
volume of the fornix in the PING cohort resemble those in another
smaller healthy cohort (5–83 years of age) that showed inverted
U-shaped curves on forniceal FA and volumes, peaking near age
20 years.
58 The magnitude of declines in forniceal volume and FA
in our TT-children is also comparable with the ﬁndings in that
cohort,
58 suggesting an accelerated aging effect of NRG1-
rs6994992 T-allele on fornix metrics.
As reduced fornix volume was found in both schizophrenic
adolescents
59 and adults,
60 our ﬁnding of smaller fornix in TT-risk
children suggests a presymptomatic endophenotype. The
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Figure 3. Examples illustrating the different patterns of the age-by-genotype interactions on cortical area (obtained from the ROI-based
model). The graphs exemplify age-related effects of NRG1 that emerge (a) or reverse (b and c) at adolescence, and a more complex age-by
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Translational Psychiatry (2014), 1–9 © 2014 Macmillan Publishers Limitedemergence of these alterations during adolescence suggests a
possible association with hormonal changes that occur during
puberty. However, longitudinal follow-up studies are required to
assess whether these children will develop psychiatric symptoms
or what factors might trigger the onset of symptoms.
Finally, smaller fornix volume in our TT-children was associated
with better episodic memory (picture sequence memory test),
which is opposite to the poorer episodic memory found in
schizophrenics.
33 In contrast, our ﬁndings suggest a positive
impact of the rs6994992 variant on neuropsychological perfor-
mance and are consistent with those reported by Keri.
61 The
author described that the TT-carriers had the highest creative-
thinking scores in healthy adults with high intellectual and
academic performance. Creative thinking and episodic memory
were previously reported to be related to psychosis.
20,23,24 The
better performance in the healthy subjects may reﬂect an
antagonistic pleiotropy effect, with better performance at younger
age and poorer performance with aging, in these individuals with
the T-risk allele. Nevertheless, abnormalities in fornix volume and
diffusivity often precede the clinical deterioration of cognitive
function and episodic memory in schizophrenics.
62–64 Therefore,
our results further support the hypothesis that NRG1-TT alleles
confer risk for the schizophrenia phenotype via lesser myelination
and atrophy of the white matter, especially the fornix.
Limitations
A potential limitation with a large scale study is the wide diversity
in genetic backgrounds of the participants. However, a major
strength of the PING data set is that the study was designed to
detect a genetic variant effect size of 0.1 with a power >0.99 and a
sample size of at least 800 children, assuming a total of seven
independent variables and a type I error rate of 1×10
−7.
However, ﬁndings from the PING study are somewhat limited by
the cross-sectional study design. For instance, outcome measures
reﬂect changes in neurophenotypes of the children at the time of
the scan, although the phenotype could have been present earlier.
Future longitudinal studies are needed to validate the role of the
type IV NRG1 in neurodevelopmental trajectories, aging and
pathology. To minimize erroneous conclusions about the effects
of age and the NRG1-rs6994992rs6994992 variant on changes in
brain structures over time, all analyses included ﬁxed traits such as
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Figure 4. Associations between rs6994992-NRG1 genotype and fornix measures over age. The fornix tract showed age and NRG1 genotype
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© 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1–9sex, ethnicity and socioeconomic status as covariates. Another
potential limitation is the possible inﬂuence of subclinical disease
on brain measures in some of these children, despite our efforts to
include only healthy children by careful screening and evaluations.
As schizophrenia and psychosis may develop subclinically years
before clinical symptoms are detectable, long-term follow-up
examinations are needed to determine whether some of these
individuals will develop these clinical disorders.
CONCLUSION
The rs6994992-polymorphism in the NRG1 gene is associated with
divergent age-related changes in gray and white matter regions.
Those changes are expressed during adolescence, a period when
symptoms for neuropsychiatric disorder commonly arise. Our
study bridges the existing gaps and validates prior smaller studies
on the effects of rs6994992-NRG1 on developmental trajectories
during childhood and adolescence, and ties in with prior ﬁndings
from neonates through adulthood. Future research on the
molecular mechanism underlying the roles of NRG1 and the
genes involved in its pathway, such as ERBB4, on brain develop-
ment and cognitive performance may ultimately lead to early
detection and improved treatment of schizophrenia and psychotic
disorders.
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